The scale described by the review
In September 2026, the UK government published the Keep Britain Working review update, which estimates the annual cost of health-related economic inactivity at about £212 billion and says roughly 300,000 people with a health condition leave work each year. The document, published on 23 September, breaks the estimate into lost output, health-related benefits, unpaid-care effects and additional NHS costs. It is an analytical estimate, not a measured saving available to an individual employer.
The review argues that earlier action can help workers remain in employment or return after sickness. It describes a role for employers, healthcare and the state. Its proposals and recommendations should not be confused with enacted new duties, and the precise economics of any specific intervention remain to be demonstrated in the workplace where it is deployed.
Where benefits fit into the employment problem
Medical insurance, occupational health, employee assistance, disability support and income protection all address parts of this challenge, but they work through different channels. A policy may pay a claim while an employee still waits for a workplace adjustment. A wellbeing service may be widely advertised yet underused by those at greatest risk of leaving. Coordination with managers and access to care matter as much as the purchase of a product.
A multinational employer needs to adapt its approach to local employment law, public healthcare, social insurance and data protection. A centrally negotiated programme can set service standards and outcome measures, while local teams manage referrals and practical return-to-work steps. The employee’s consent and medical confidentiality must remain central.
An evidence-led employer response
The first useful measurement is a baseline: incidence and length of sickness absence, time from referral to assessment, adjustments offered, sustainable return to work and subsequent exits. Aggregate measures should be segmented where lawful to understand which populations are poorly served. Costs of premiums, administration and managers’ time belong alongside claims and retention measures.
A pilot could focus on one work population and one defined route to care. Employers should set a comparison period, agree who owns follow-up and record whether an employee remains at work six or twelve months later. Improvement in referral speed alone does not establish that a programme prevented an exit. A credible evaluation considers alternative explanations and the characteristics of people who received support.
Supplier and manager accountability
A coherent programme needs a named owner for the interval between an employee’s first difficulty and formal long-term absence. Occupational-health advisers, insurers and managers can each assume another party is responsible. A process map should define referrals, reasonable adjustments, response times, escalation and confidentiality. Employees need to know how to seek help without believing that medical information will automatically circulate to their line manager.
Procurement should ask suppliers for outcomes they can actually observe, such as appointment lead times, treatment completion and sustained return to work, while acknowledging attribution limits. Employees with the most severe needs may have worse outcomes despite receiving more intensive support. Comparisons must adjust for the population served rather than rewarding providers for selecting easy cases. That discipline makes a credible business case and protects the purpose of the benefit.
What boards can ask
Boards should request an integrated view of employee health risk, service delivery and economic results rather than isolated benefit utilisation reports. They can ask where care is delayed, which supplier is accountable and how the company knows that interventions are reaching workers before an absence becomes prolonged. This is especially relevant where workforce turnover and disability claims are material.
The review strengthens the case for examining prevention and retention as operating decisions as well as benefit costs. Its national estimate gives context, the employer’s own evidence should determine investment. For advisers and insurers, a useful offer would connect clearly defined services to outcomes that can be tested without making unsupported promises of savings.
